Since IGF2BP3 recognizes m6A modification of Nrf2 mRNA and stabilizes it, IGF2BP3 knockdown significantly promotes ferroptosis of hepatocellular carcinoma cells after administration of sorafenib [95]. The gene discussed is IGF2BP3; the disease is hepatocellular carcinoma.